Ayala Pharmaceuticals Inc
(ADXS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 10-2014 | 10-2013 | 10-2012 | 10-2011 | 10-2010 | |
| Sales | 1,000 | 0 | 0 | 0 | 509 |
| Gross Profit | 1,000 | N/A | N/A | N/A | 509 |
| Operating Expenses | 20,539 | 14,694 | 12,335 | 13,019 | 8,435 |
| Operating Income | -19,539 | -14,694 | -12,335 | -13,019 | -7,926 |
| Interest Expense | 0 | 988 | 4,537 | 4,699 | 3,815 |
| Other Income | 656 | -5,031 | 4,455 | 9,223 | 650 |
| Pre-tax Income | -18,882 | -20,712 | -12,417 | -8,495 | -11,091 |
| Income Tax | -2,357 | -725 | -347 | -380 | -279 |
| Net Income Continuous | -16,525 | -19,987 | -12,070 | -8,116 | -10,812 |
| Net Income | $-16,525 | $-19,987 | $-12,070 | $-8,116 | $-10,812 |
| EPS Basic Total Ops | -1,163.42 | -4,917.54 | -5,985.01 | -0.04 | -0.07 |
| EPS Basic Continuous Ops | -1,158.62 | -4,782.96 | -5,643.82 | -0.04 | -0.07 |
| EPS Diluted Total Ops | -1,163.42 | -4,917.54 | -5,985.01 | -0.04 | -0.07 |
| EPS Diluted Continuous Ops | -1,158.62 | -4,782.96 | -5,643.82 | -0.04 | -0.07 |
| EBITDA(a) | $-19,335 | $-14,411 | $-10,540 | $-12,376 | $-7,237 |